Unicycive Therapeutics Stock (NASDAQ: UNCY) stock price, news, charts, stock research, profile.
Open | $0.38 |
Close | $0.39 |
Volume / Avg. | 1.98M / 2.42M |
Day Range | $0.38 - $0.42 |
52 Wk Range | 0.20 - 1.82 |
Market Cap | $37.27M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 0.85% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Unicycive Therapeutics (NASDAQ:UNCY) through any online brokerage.
Other companies in Unicycive Therapeutics’s space includes: Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP), Gain Therapeutics (NASDAQ:GANX), Curis (NASDAQ:CRIS) and T2 Biosystems (NASDAQ:TTOO).
Unicycive Therapeutics has a consensus price target of $5.25.
The stock price for Unicycive Therapeutics (NASDAQ: UNCY) is $0.395 last updated September 18, 2024 at 6:29 PM EDT.
There are no upcoming dividends for Unicycive Therapeutics.
Unicycive Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Unicycive Therapeutics.
Unicycive Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.